Groundbreaking Kicks Off Construction of New Cancer Care Center of DecaturPosted:
Sept. 24, 2008
FOR IMMEDIATE RELEASE
For More Information Contact: Mike Cassell, DMH Marketing Director, 876-3232
Tricia Henning, CCSCI Project Manager, 876-6600
GROUNDBREAKING KICKS OFF CONSTRUCTION OF NEW CANCER CARE CENTER OF DECATUR
Cancer Care Specialists of Central Illinois, S.C., (CCSCI) and Decatur Memorial Hospital Cancer Care Institute came together today to break ground on the new Cancer Care Center of Decatur, located at 210 W. McKinley Avenue in Decatur.
Designed to enhance patient convenience, the one-story 55,400 square foot facility will unite outpatient Radiation Oncology, Medical Oncology, Medical Imaging, Cancer Research, Complementary Services, and education and outreach services under one roof. Construction will begin in October by Otto Baum Company-Decatur Division, with completion of the facility in September 2009.
"A cancer diagnosis is overwhelming," said Ken Smithmier, President & CEO, Decatur Memorial Hospital. "By having all the outpatient cancer services, technology, and treatment together, patients will have peace of mind knowing they will receive everything they need to fight their cancer under one roof."
Currently, the DMH Radiation Oncology is on the ground floor of Decatur Memorial Hospital, while Cancer Care Specialists of Central Illinois is located at 2880 N. Monroe Street in Decatur.
The Radiation Oncology program of DMH will continue to provide state-of-the-art technologically advanced treatment to outpatients. Available will be the most sophisticated approaches including RapidArc Radiotherapy, Intensity Modulated Radiation Therapy (IMRT) and Image Guided Radiation Therapy (IGRT). Radioisotopes and radio immunotherapy will also be offered.
"This new comprehensive facility will be the premier center for cancer services in central Illinois," said Edward Elliott, M.D., medical director, Radiation Oncology. "Patients will experience a comfortable, supportive, healing environment while they receive the very best in cancer treatment."
The Medical Oncology program of CCSCI will provide an entire range of diagnostic and therapeutic modalities for hematologic and neoplastic disorders, including chemotherapy, infusion therapy, immunotherapy, hormone therapy and pain management. A full range of convenient diagnostic laboratory testing will be available through a Clinical Laboratory Improvement Amendments (CLIA) certified diagnostic laboratory. A chemotherapy pharmacy for compounding and dispensing both injectable and oral medications will enhance patient services. Imaging with the latest CT-PET technology located within the center will be used to evaluate and monitor response to treatment and will be available on-site. Patients will receive infusions in either treatment suites or private rooms (accommodating 34 patients in treatment suites and six in private rooms). In addition, a patient services coordinator familiar with the facility and assistance programs will help patients and their families obtain all available support services. Preventive oncology and genetic counseling will also be available.
"The new Cancer Care Center of Decatur is the first facility in our region to offer the next generation of cancer services, ranging from supportive care and groundbreaking Phase I research studies to complementary care, all designed to help meet the needs of patients and families," said James Wade, III, M.D., President, Cancer Care Specialists of Central Illinois.
The Cancer Research program, provided jointly by CCSCI and DMH, will continue its strong tradition of providing a broad menu of the latest cancer treatment and prevention studies. The Central Illinois Community Clinical Oncology Program, which is directly funded by the National Cancer Institute, will base its operations in the new facility. This nationally recognized program has received several awards including the Harry Hynes Award for Research Excellence from the National Cancer Institute and currently offers more than 80 clinical trials covering all tumor types. The Cancer Research program also is a component of the University of Chicago Cancer Research network. The Cancer Research Program will also include, for the first time, Phase I projects. These studies will be the first nationwide to test newly developed anti-cancer agents. In addition, the DMH Tumor Registry, which tracks the treatment and outcomes of patients in our region and is approved and certified by the American College of Surgeons, will be used for ongoing research and will be staffed by experienced registrars.
Complementary Services will round out clinical services. To help patients through their illness and therapy, a full battery of integrative supportive approaches will be offered for the patients' emotional and spiritual needs. These include nutritional counseling, movement therapy (yoga, tai chi), stress reduction therapies (meditation, guided imagery, massage, reflexology), as well as art and music therapy. The center will also include an area for a patient library and a multimedia classroom for community education.
"Over the last twenty-five years, we have built all the parts needed for a world class cancer program" Dr. Wade said. "The new Cancer Care Center of Decatur will be the first center in Central Illinois to provide a complete spectrum of oncology services to patients and families, including more than 80 cancer research studies, full diagnostic capability with PET CT scanning, complete spectrum of radiation oncology services, a full range of diagnostic laboratory services, chemotherapy infusion services, and office space for medical oncology and radiation oncology specialists - all in one location. No other cancer center in Central Illinois offers such a full range of care for those afflicted with cancer in our region. Patients, families, and the community will benefit for years to come from this new building and the outstanding capabilities of the people who will staff it."
NOTE TO MEDIA: Physicians who will have offices in the new cancer center include:
Edward Elliott, M.D., Medical Director
Mary Anne de Paz, M.D.
Renata Moore, M.D.
Harold Yoon, M.D.
James Wade, III, M.D., Medical Director
Dolores Estrada-Garcia, M.D.
Benjamin Esparaz, M.D.
Perry Guaglianone, M.D.
Maria Grosse Perdekamp, M.D.
Mario Velasco, Jr., M.D.